Piqur Therapeutics Overview
- Year Founded
-
2011
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Liquidation
Piqur Therapeutics General Information
Description
Developer of targeted oncology and dermatology medicines intended for the treatment of cancer and genetic diseases. The company's medicines aim at extending and improving the lives of cancer patients, enabling cancer patients to recover and have a healthy life.
Contact Information
Website
www.piqur.comCorporate Office
- Arnold Böcklin-Strasse 25
- C/o Wirtschafts-Treuhand AG
- 4051 Basel
- Switzerland
Corporate Office
- Arnold Böcklin-Strasse 25
- C/o Wirtschafts-Treuhand AG
- 4051 Basel
- Switzerland
Piqur Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Bankruptcy: Liquidation | 29-Sep-2021 | Completed | Bankruptcy: Liquidation | |||
| 11. Later Stage VC | 15-Apr-2019 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series B) | 15-Nov-2017 | Cancelled | Generating Revenue | |||
| 9. Later Stage VC (Series A3) | 01-Sep-2017 | Completed | Generating Revenue | |||
| 8. Early Stage VC (Series A2) | 16-Jul-2015 | Completed | Generating Revenue | |||
| 7. Early Stage VC (Series A) | 08-Apr-2014 | Completed | Generating Revenue | |||
| 6. Seed Round | 05-Sep-2013 | Completed | Generating Revenue | |||
| 5. Grant | Completed | Generating Revenue | ||||
| 4. Seed Round | 01-Oct-2012 | $3.1M | $3.1M | Completed | Generating Revenue | |
| 3. Seed Round | Completed | Startup |
Piqur Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary shares | ||||||||
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A | ||||||||
| Ordinary shares | ||||||||
| Ordinary shares | ||||||||
| Ordinary shares | ||||||||
| Ordinary shares | 43,308 | $0.100210 | $1.54 | $1.54 | 1x | $1.54 | 0.74% | |
| Ordinary shares | 50,000 | $0.100210 | $0.2 | $0.2 | 1x | $0.2 | 0.85% |
Piqur Therapeutics Comparisons
Industry
Financing
Details
Piqur Therapeutics Competitors (79)
One of Piqur Therapeutics’s 79 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Abeona Therapeutics | Corporation | Cleveland, OH | ||||
| IFM Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Auron Therapeutics | Venture Capital-Backed | Newton, MA | ||||
| Argos Therapeutics | Venture Capital-Backed | Durham, NC |
Piqur Therapeutics Patents
Piqur Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210299133-A1 | Treatment of squamous cell carcinoma | Inactive | 07-Aug-2018 | ||
| US-20250367210-A1 | Treatment of squamous cell carcinoma | Pending | 07-Aug-2018 | ||
| WO-2020030708-A1 | Treatment of squamous cell carcinoma | Inactive | 07-Aug-2018 | ||
| WO-2019101853-A1 | Treatment of skin disorders | Inactive | 23-Nov-2017 | ||
| WO-2017198346-A1 | Treatment of neurological disorders | Inactive | 18-May-2016 | A61K31/5377 |
Piqur Therapeutics Signals
Piqur Therapeutics FAQs
-
When was Piqur Therapeutics founded?
Piqur Therapeutics was founded in 2011.
-
Where is Piqur Therapeutics headquartered?
Piqur Therapeutics is headquartered in Basel, Switzerland.
-
What is the size of Piqur Therapeutics?
Piqur Therapeutics has 9 total employees.
-
What industry is Piqur Therapeutics in?
Piqur Therapeutics’s primary industry is Drug Discovery.
-
Is Piqur Therapeutics a private or public company?
Piqur Therapeutics is a Private company.
-
What is Piqur Therapeutics’s current revenue?
The current revenue for Piqur Therapeutics is .
-
How much funding has Piqur Therapeutics raised over time?
Piqur Therapeutics has raised $97.7M.
-
Who are Piqur Therapeutics’s competitors?
Genentech, Abeona Therapeutics, IFM Therapeutics, Auron Therapeutics, and Argos Therapeutics are some of the 79 competitors of Piqur Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process